Roivant Sciences (ROIV) Shares Outstanding (2020 - 2026)
Roivant Sciences (ROIV) Shares Outstanding (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 6,012.74 Bn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 47.82 Bn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.44 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 11.23 Bn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 254.10 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 400.00 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 62.19 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 198.10 Mn |
| 10 | Roivant Sciences | 24.35 Bn | 25.12 Bn | - | 693.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 693.86 Mn |
| Dec 31, 2025 | 696.86 Mn |
| Sep 30, 2025 | 680.95 Mn |
| Jun 30, 2025 | 680.29 Mn |
| Mar 31, 2025 | 725.40 Mn |
| Dec 31, 2024 | 722.72 Mn |
| Sep 30, 2024 | 735.47 Mn |
| Jun 30, 2024 | 735.82 Mn |
| Mar 31, 2024 | 783.25 Mn |
| Dec 31, 2023 | 800.59 Mn |
| Sep 30, 2023 | 770.23 Mn |
| Jun 30, 2023 | 759.27 Mn |
| Mar 31, 2023 | 712.79 Mn |
| Dec 31, 2022 | 713.32 Mn |
| Sep 30, 2022 | 699.89 Mn |
| Jun 30, 2022 | 695.88 Mn |
| Mar 31, 2022 | 669.75 Mn |
| Dec 31, 2021 | 686.59 Mn |
| Sep 30, 2021 | 650.23 Mn |
| Jun 30, 2021 | 222.08 Mn |